phosphodiesterase

Pfizer Amaryllis trial ends in disappointment: no improvement in Huntington's disease symptoms

Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD

December 16, 2016

#Buzzilia, day 1: Jeff and Ed's roundup of happenings from the opening day of the HD World Congress in Rio de Janeiro

September 15, 2013

Watch Ed Wild's address to the European Huntington's Association on how HD research works and the most promising poss

October 10, 2012

CHDI and Pfizer announce exciting animal work and plans for a human trial with a drug targeting 'phosphodiesterases'.

June 7, 2012